Laughrea, P.-A. and Hébert, M. (2022) “Staying ahead of dupilumab-associated ocular surface disease”, Canadian Eye Care Today. Toronto, Canada, 1(2), pp. 8–13. doi: 10.58931/cect.2022.1212.